Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients

NCT03173859 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Delayed initiation

Conditions

Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG: Abiraterone
DRUG: Apalutamide

Sponsor

University of Athens